Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P80404 (
GABA transaminase
)
786
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The enzymes responsible for both the formation and degradation of gamma-aminobutyric acid (GABA) are known to exist in the thyroid gland. The thyroid is also equipped with high- and low-affinity uptake mechanisms for GABA. We therefore investigated the effects of GABA on basal and
TSH
-stimulated thyroid hormone secretion in the mouse according to the McKenzie technique. Iodine-deficient mice were pretreated with Na125I and thyroxine. GABA (1-100 nmol/kg iv) did not affect basal radioiodine levels. However, the neurotransmitter inhibited the
TSH
-induced increase in blood radioiodine levels. Thus, the increase after iv injection of
TSH
at 70 microU/animal (205 +/- 15%) was inhibited by GABA at 10 nmol/kg (to 155 +/- 14%; P less than 0.05). In contrast, a dose as high as 100 nmol/kg was necessary to inhibit the effect of
TSH
at its high dose of 350 microU/animal. The GABAA-receptor antagonist bicuculline counteracted this inhibitory action of GABA. Furthermore, pretreatment with the inhibitor of GABA-degrading enzyme
GABA transaminase
(gamma-vinyl GABA) impaired the stimulatory effect of
TSH
on blood radioiodine levels. Thus, at 350 microU/animal,
TSH
increased blood radioiodine levels by 363 +/- 34% in controls vs by only 246 +/- 32% in animals pretreated with gamma-vinyl-GABA (P less than 0.05). We conclude that GABA is an inhibitor of
TSH
-stimulated thyroid hormone secretion.
...
PMID:GABA inhibits thyroid hormone secretion in the mouse. 248 71
